Drug discovery company Evotec upgrades IFS, setting the company up for the future & helping deliver on its ‘research never stops’ promise 

Evotec is a fast-growing, global, high-quality provider in the drug discovery field and has a 20-year corporate history. Founded in 1993, the Company has built substantial drug discovery expertise and deep internal knowledge in the fields of metabolic diseases, neuroscience, pain, inflammation and oncology. By leveraging these skills and expertise, the company intends to develop best-in-class differentiated  therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Headquartered in Hamburg, Germany, the Evotec Group operates worldwide with subsidiaries in Germany, UK and USA.

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec operates worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. 


Assets Type:

pdf

"Having an out-of-thebox system made the upgrade easier and will be easier to support"

Trevor Jones

Senior Accountant, Evotec

About Evotec

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec operates worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic.


Benefits seen using IFS

  • Enhanced reporting capabilities
  • Seamless third party integrations
  • 28% improvement in planned maintenance performance SLAs
  • Upgrade completed ahead of schedule, bringing project in under budget

Visit Website:

Related Customer Stories

    Back to customer directory
back to top back to top haut de page